Clinical Trial Posts on Medivizor
Navigation Menu

Clinical Trial Posts on Medivizor

Do You Understand Clinical Trials?

Do You Understand Clinical Trials?

Posted by on Mar 13, 2017 in Blog | 1 comment

In two previous posts, What Do You Think About Clinical Trials?  and What Do You Think? Medivizor’s Clinical Trials Perception Survey Results, we learned your perceptions of clinical trials.  As a follow-up, we have a short, very useful explainer video produced by the European Patients’ Academy (EUPATI) describing some of the key features of...

Read More

What Do You Think? Medivizor’s Clinical Trials Perception Survey Results

What Do You Think?  Medivizor’s Clinical Trials Perception Survey Results

Posted by on Nov 12, 2016 in Blog | 2 comments

In June, we published a post  called What Do You Think About Clinical Trials?  The post included the results of several surveys about perceptions of clinical trials including the results of  a study conducted by MaPS/Millward Brown Analytic and Memorial Sloan Kettering (MSKCC). Medivizor’s Clinical Trials Perception Survey Results In our post...

Read More

What Do You Think About Clinical Trials?

What Do You Think About Clinical Trials?

Posted by on Jun 23, 2016 in Blog | 7 comments

Please take this short survey on Clinical Trials…then read on! Surveys on Perceptions of Clinical Trials If you are like most people, you may not have a very positive opinion of clinical trials.  At least that is what a recent survey conducted by MaPS/Millward Brown Analytic and Memorial Sloan Kettering (MSKCC) suggests.  Only 40% of those...

Read More

Infliximab or biosimilar? A comparison between two similar drugs in patients with rheumatoid arthritis

Posted by on May 14, 2016 in Rheumatoid Arthritis | 0 comments

In a nutshell This study examined whether switching from infliximab (Remicade) to a similar drug had any influence on performance or side effects in patients with rheumatoid arthritis (RA). This study concluded that switching from infliximab to CT-P13 was safe and effective for patients with RA. Some background In rheumatoid arthritis (RA),...

Read More

A combination of afatinib and paclitaxel in EGFR-mutant non-small cell lung cancer

Posted by on Feb 7, 2016 in Lung cancer | 0 comments

In a nutshell This study aimed to determine the efficacy of a combination of the anticancer drugs afatinib (Gilotrif) and paclitaxel (Taxol) to treat non-small cell lung cancer (NSCLC), compared to chemotherapy alone. The study found that a combination of these drugs significantly improved progression free survival (PFS, time from treatment until...

Read More

The potential of Nivolumab in treating advanced NSCLC

Posted by on Jan 25, 2016 in Lung cancer | 0 comments

In a nutshell This study compared the efficacy of antitumor drugs nivolumab (Opdivo) and docetaxel (Taxotere) in the treatment of advanced non-small-cell lung cancer (NSCLC). The study concluded that nivolumab has better activity in advanced nonsquamous NSCLC which express the ligand PD-L1 and has a safer toxicity profile overall than docetaxel. Some...

Read More

Low vitamin D levels associated with infertility

Posted by on Jan 10, 2016 in Infertility | 0 comments

In a nutshell This study looked at vitamin D levels and pregnancy rates in patients undergoing in vitro fertilization (IVF). The study found that pregnancy rates were signficantly higher in the patients who had higher vitamin D levels. Some background Vitamin D is important for good health. The main source of vitamin D is from the action of...

Read More

Type 2 Diabetes – Which drug combination reduces blood sugar while causing the least side effects?

Posted by on Jun 12, 2015 in Diabetes mellitus | 0 comments

In a nutshell This study investigated the blood sugar reduction and sid-effects associated with 4 different drug combinations in type 2 diabetes. Some background Metformin (Glucophage) decreases glucose production. It is often the first choice of treatment for type 2 diabetes. Commonly, other drugs are prescribed to be taken alongside...

Read More

Diabetes and Nanotechnology

Diabetes and Nanotechnology

Posted by on Jun 10, 2013 in Blog, Diabetes mellitus | 0 comments

Before humans are involved in clinical trials, a lot of animal testing occurs.  When something works in animals, there is hope that it will work in people. That’s why the news of nanotechnology applied to diabetes in animals is interesting. Diabetes Research The work is being done through a cooperative effort between North Carolina State University and...

Read More

Use of Radionuclide and hybrid imaging in the assessment of recurrent prostate cancer

Posted by on May 28, 2013 in Prostate cancer | 0 comments

In a nutshell This article analyzes the latest information on imaging tests used in checking for prostate cancer recurrence. Radionuclide imaging and hybrid imaging are among the imaging tests reviewed in this article. Some background Recurrent prostate cancer is a cancer that has come back after initial treatment. Most imaging tests have limited...

Read More